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Key messages
 ► The condom and the oral contraceptive 
pill continue to be the most commonly 
used contraceptive methods in Britain.
 ► A significant increase in long- acting 
reversible contraceptive (LARC) 
use has been observed, particularly 
among women under 25 years of age, 
suggesting strategies to increase uptake 
have been successful.
 ► A significant increase was also observed 
in the proportion of women reporting no 
current contraceptive use.
ABSTRACT
Aim To describe prevalence and trends in 
contraceptive method use in Britain through a 
comparison of the second and third National 
Surveys of Sexual Attitudes and Lifestyles 
(Natsal-2 and Natsal-3).
Methods Cross- sectional probability sample 
surveys. General population sample of women 
aged 16–44 years, resident in Britain, with ever- 
experience of vaginal sex and, for analysis by 
sociodemographic characteristics, vaginal sex in 
the last year. Main outcome measure was current 
contraceptive method use (‘usual these days’), 
categorised by effectiveness.
Results Prevalence of current contraceptive use 
among women who had ever had vaginal sex 
declined between Natsal-2 and Natsal-3, 83.5% 
(95% CI 82.4 to 84.5) and 76.4% (95% CI 
75.0 to 77.7), respectively. The condom and oral 
contraceptive pill remain the most commonly 
used methods. One in five women reported use 
of a most effective method. While no difference 
was found between surveys in use of most 
effective methods, a decline in sterilisation use 
was compensated by an increase in long- acting 
reversible contraceptive (LARC) use. Increased 
LARC use was particularly evident among under- 
25s compared with women aged 40–44 years 
(OR 11.35, 95% CI 3.23 to 39.87) and a decline 
was observed among those with two or more 
children relative to those with none (OR 0.21, 
95% CI 0.13 to 0.35).
Conclusions Strategies to improve access to 
LARC methods have been particularly successful 
in increasing uptake among young people in 
the first decade of the 21st century. Whether 
this trajectory is maintained given changing 
sociodemographic characteristics and more 
recent financial cuts to sexual health service 
provision will warrant investigation.
InTRoduCTIon
Unintended pregnancy continues to be 
a public health problem in Europe.1 In 
Britain, an estimated one in five pregnan-
cies are not planned.2 3 While contracep-
tion can prevent unintended pregnancy, 
the effectiveness and continuation rates 
of available methods vary greatly. The 
last half century has seen major changes 
in patterns of fertility and its control. The 
interval between onset of sexual activity 
and childbearing has widened, and desired 
and actual family size has decreased, thus 
increasing the time period during which 
effective contraception is most required.3
The 21st century has seen a range 
of policy- related initiatives aimed at 
reducing rates of unintended pregnancy in 
Britain, many of them specifically focused 
on increasing awareness and uptake 
French RS, et al. BMJ Sex Reprod Health 2020;46:200–209. doi:10.1136/bmjsrh-2019-200474 201
Original research
of long- acting reversible methods of contraception 
(LARC). Mounting evidence of the cost effectiveness 
of LARC methods prompted the National Institute for 
Health and Care Excellence (NICE) to publish guid-
ance in 2005 recommending the increased use of such 
methods.4 The income of general practitioners was 
linked to performance against Quality and Outcome 
Framework (QOF) goals, and in 2009 a new set of 
indicators on contraception was introduced, including 
provision of information about LARC methods.5 6
Thus far, there have been few national data with 
which to assess progress towards the goals of these 
initiatives. Efforts to do so have relied on routinely 
collected data such as prescribing rates in primary care 
which provide information about rates of method use, 
but not users.7 Survey data on specialist contraceptive 
service use has reported an increase in LARC method 
use over the last decade.8 However, it offers limited 
opportunities to explore correlates of use associated 
with user sociodemographic characteristics and sexual 
and reproductive behaviour, and does not include 
women who obtain methods from other suppliers, 
such as general practice and pharmacies.
Data from the two most recent National Surveys 
on Sexual Attitudes and Lifestyles (Natsal-2 and 
Natsal-3) provide an opportunity to examine the mix 
of contraceptive methods used by women in Britain at 
the start of the 21st century and to describe changes 
in patterns of use. Specifically, the data enable us to 
determine whether there has been a change in the use 
of the most effective contraceptive methods, how this 
varies between subgroups of women, and with what 
apparent effect on use of other methods. In this article 
we describe trends in contraceptive method use in 
Britain between Natsal-2 and Natsal-3 with the aim of 
exploring how changes in patterns of fertility and in 
policy may have impacted on method use, in particular 
LARC methods.
MeThodS
Natsal is a clustered and stratified probability survey of 
the sexual attitudes and behaviours of men and women 
resident in Britain. It has been carried out roughly 
decennially in 1990 (Natsal-1), 1999–2000 (Natsal-2) 
and 2010–2012 (Natsal-3). Data from Natsal-1 have 
not been included in this analysis since contraceptive 
implants were not available in Britain until 1991 and 
the levonorgestrel- releasing intrauterine system (LNG- 
IUS) was not marketed until 1995. In Natsal-2, 11 161 
participants aged 16–44 years (6399 women and 4762 
men) were interviewed; Natsal-3 included 15 162 
participants aged 16–74 years (8869 women and 6293 
men). Households within postcode sectors, the primary 
sampling units, were selected and one eligible adult at 
the address randomly selected. Data were weighted 
to take account of unequal probabilities of selec-
tion and non- response. Computer- assisted personal 
interviews (CAPI) were used for data collection and 
computer- assisted self- interviews (CASI) were used 
for more sensitive questions. The response rates for 
Natsal-2 and Natsal-3 were 65.4% and 57.7%, respec-
tively, and in Natsal-3 the co- operation rate (ie, of all 
eligible addresses contacted) was 65.8%. Full details of 
the survey methods have been described elsewhere.9
In this article we use responses to the Natsal question 
about contraceptive methods currently used: “Which 
would you say is your most usual method these days?”. 
Participants who reported in CASI ever having had 
sexual intercourse with an opposite sex partner were 
presented with a list of different contraceptive methods 
to select. Analysis was first confined to women aged 
under 45 years who reported ever having had vaginal 
sex to provide population estimates on current use 
of different contraceptive methods and to investi-
gate changes in use between Natsal-2 and Natsal-3. 
When examining user characteristics by contraceptive 
method use the analysis was then confined to women 
who had vaginal sex in the last year and those who 
were not pregnant at the time of interview. Although 
participants were asked in Natsal-3 whether they or 
their partner were trying to conceive and whether 
they had had a hysterectomy, these questions were 
not asked in Natsal-2. Therefore, women in Natsal-3 
who reported that they were trying to conceive or had 
had a hysterectomy were kept in the analysis to allow 
comparison between the two surveys.
Contraceptive methods were characterised by level 
of effectiveness into: Most effective (female/male ster-
ilisation, intrauterine device (IUD), intrauterine system 
(IUS), implant); Effective (oral contraceptive pill, 
injection, transdermal patch); Less effective (condom, 
Femidom, cap, spermicides, rhythm method, with-
drawal) and No method used. The categorisation was 
based on typical rather than perfect user failure rates.10 
In analysis, the categories were grouped hierarchically 
so that if more than one method was reported, the 
more effective method took precedence. The inject-
able contraceptive depot medroxyprogesterone acetate 
(DMPA, Depo- Provera) was not included in the most 
effective method category, despite being categorised as 
a LARC by NICE, since this method is generally placed 
in the same tier of effectiveness as oral contraceptive 
pills. Although the contraceptive effect of injections 
lasts 12 weeks, the method can be stopped without the 
need to see a health provider and discontinuation rates 
are similar to those of oral contraception. The use 
of DMPA, in contrast to other LARCs, has not been 
shown to reduce unintended pregnancy rates.11 When 
examining user characteristics, permanent methods 
(ie, female and male sterilisation) and LARC methods 
were analysed separately.
Usual contraceptive method use was examined 
by demographic variables: age, ethnicity, religion, 
academic qualifications, Index of Multiple Depriva-
tion, and relationship status. We also examined sexual 
and reproductive health behaviour variables: sexually 
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Table 1 Usual use of contraceptive methods among women aged 16–44 years who ever reported vaginal intercourse: Natsal-2 and 
Natsal-3
Denominator (unweighted, weighted)*
Natsal-2: usual use Natsal-3: usual use
5178, 4651 5237, 3657
n % (95% CI) n % (95% CI)
Most effective methods 1141, 1077 21.5 (20.4 to 22.8) 944, 762 21.1 (19.7 to 22.6)
  Intrauterine device 265. 221 4.4 (3.9 to 5.0) 230. 187 5.2 (4.4 to 6.1)
  Hormonal intrauterine system (Mirena) 44, 35 0.7 (0.5 to 1.0) 105, 96 2.6 (2.1 to 3.3)
  Implant 15, 14 0.3 (0.2 to 0.5) 348, 194 5.4 (4.8 to 6.0)
  Male sterilisation 445, 446 8.9 (8.1 to 9.8) 162, 177 4.9 (4.1 to 5.8)
  Female sterilisation 382, 370 7.4 (6.6 to 8.3) 106, 114 3.2 (2.6 to 3.9)
Effective methods† 1940, 1747 34.9 (33.5 to 36.4) 1953, 1194 33.1 (31.6 to 34.6)
  Pill 1769, 1599 32.0 (30.6 to 33.4) 1741, 1064 29.5 (28.1 to 30.9)
  Injections 171, 148 3.0 (2.5 to 3.5) 210, 128 3.6 (3.0 to 4.1)
Less effective methods† 1641, 1417 28.3 (27.0 to 29.7) 1356, 940 26.1 (24.6 to 27.5)
  Male condom 1360, 1184 23.7 (22.4 to 25.0) 1229, 833 23.1 (21.7 to 24.5)
  Cap/diaphragm† 45, 31 0.6 (0.4 to 0.9) – –
  Natural family planning (rhythm) 104, 85 1.7 (1.3 to 2.1) 37, 35 1.0 (0.7 to 1.4)
  Withdrawal 173, 150 3.0 (2.6 to 3.5) 92, 75 2.1 (1.6 to 2.6)
No method used 1030, 826 16.5 (15.5 to 17.6) 1173, 853 23.6 (22.3 to 25.0)
  No vaginal sex in last year 463, 309 6.0 (5.4 to 6.7) 408, 271 7.4 (6.6 to 8.3)
*Denominator is Natsal population aged 16–44 years, excluding those who have never had vaginal intercourse.
†Numbers too small for patch (effective), cap/diaphragm in Natsal-3 (less effective), female condom (less effective), spermicides (less effective)
transmitted infection (STI) in the last year, frequency 
of sex in the last 4 weeks, and parity.
All statistical analyses were conducted using the 
Stata (version 13) (StataCorp, College Station, TX, 
USA) survey commands, in order to account for the 
weighting, clustering, and stratification of the survey 
data. Prevalence of method use was estimated. Bivar-
iate analysis was used to describe associations between 
method use and selected sociodemographic charac-
teristics and sexual and reproductive behaviours. The 
odds ratios (ORs) for the difference in prevalence 
between Natsal-2 and Natsal-3 were examined; 95% 
confidence intervals (95% CIs) are used throughout.
ReSulTS
In Natsal-3, 5237 of the 5842 women aged 16–44 years 
reported that they had ever had vaginal intercourse. 
Over three- quarters of these women (76.4%, 95% CI 
75.0 to 77.7) reported current use of any contracep-
tion. In Natsal-2, 5178 of the 6399 women reported 
that they had ever had vaginal intercourse. Current 
contraceptive use was reported by 83.5% (95% CI 
82.4–84.5) of women, significantly higher than the 
prevalence observed in Natsal-3. The condom and oral 
contraceptive pill were the methods most commonly 
used by women and this was observed in Natsal-2 and 
Natsal-3 (table 1). In the most effective contracep-
tive method category, male sterilisation was replaced 
by implants as the most commonly cited method 
over the last decade (8.9% and 0.3%, respectively, 
in Natsal-2 compared with 4.9% and 5.4%, respec-
tively, in Natsal-3). Use of the patch, female condom, 
cap or diaphragm and spermicides was very low in 
both surveys. Around one in five women reported in 
Natsal-3 that they had not used any method of contra-
ception in the last year, however 7.4% (95% CI 6.6 
to 8.3) of all women reported no vaginal sex in the 
last year, 7.6% (95% CI 6.8 to 8.5) were trying to 
conceive, 4.4% (95% CI 3.8 to 5.0) were pregnant 
at the time of interview and 1.4% (95% CI 1.0–2.0) 
had had a hysterectomy. Women were not asked in 
Natsal-2 whether they were trying to conceive or if 
they had had a hysterectomy.
No significant difference was observed in the odds 
of use of the most effective and effective methods 
between the surveys (figure 1). However, in the most 
effective category the overall change in likelihood of 
use masks considerable differences in contraceptive 
methods used within this category, particularly the 
move from permanent to reversible methods. Increases 
observed in odds of reporting current use of implants 
(OR 19.95, 95% CI 10.92 to 36.45) and the IUS (OR 
3.84, 95% CI 2.57 to 5.74) were offset by a significant 
decline in odds of reporting use of male and female 
sterilisation (OR 0.53, 95% CI 0.43 to 0.66 and OR 
0.41, 95% CI 0.31 to 0.53, respectively). Significant 
increases in the likelihood of reporting that they 
were currently not using any method were observed 
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Figure 1 Changes between Natsal-2 and Natsal-3 in the odds of usual contraceptive method use in the last year: sexually experienced*Reporting having 
ever had vaginal intercourse among women aged 16–44 years. CI, confidence interval; OR, odds ratio.
between Natsal-2 and Natsal-3 (OR 1.61, 95% CI 1.40 
to 1.85).
The demographic and lifestyle characteristics by 
contraceptive method effectiveness category or non- 
method use among women who reported vaginal 
sexual intercourse in the last year for Natsal-3 are 
shown in table 2. Women who reported current use 
of female or male sterilisation were significantly more 
likely to be older (≥35 years), married and have two 
or more children. Women identifying as ‘white ‘were 
significantly more likely to report use of sterilisation 
when compared with Asian women and women of 
mixed or other ethnicity. The only significant associ-
ation found among LARC users was that they were 
more likely to have had two or more children.
Use of effective methods peaked in the 18–19 years 
age group (56.0%, 95% CI 50.2 to 61.5). Asian women 
were significantly less likely than White women to 
report effective contraceptive method use, and usual 
use was significantly lower among women of Muslim 
or Hindu faith compared with Christians or those with 
no faith. Usual effective method use was significantly 
higher among women studying for or with academic 
qualifications compared with those with fewer qual-
ifications. Prevalence was highest among unmarried 
women, including those cohabiting. Those with two 
or more children were significantly less likely to use 
these methods. Prevalence increased incrementally 
with frequency of sex and women using these methods 
were significantly more likely to report an STI in the 
last year.
Users of the less effective methods were significantly 
more likely to be younger (use peaking in the 16–17 
years age group). There were differences in the ethnic 
and religious profiles of users. Around half of Asian 
women (41.2%, 95% CI 34.1 to 48.7) compared 
with 22.3% (95% CI 20.8 to 24.0) of White women 
reported current use of less effective methods. Higher 
prevalence of less effective use was reported among 
participants of Muslim and Hindu faiths. Use of less 
effective methods was significantly higher among those 
who were currently studying or had achieved higher 
academic qualifications, those having less frequent sex 
and those without any children.
Among those who reported vaginal sex in the last year 
and were not currently pregnant, 17.5% (95% CI 16.3-
18.9) reported no current method, although this reduced 
to 9.0% (95% CI 7.9 to 10.3) when those who were trying 
to conceive or had had a hysterectomy were excluded from 
the analysis. The proportion of those who reported not 
currently using any contraceptive method increased incre-
mentally with age, being reported by nearly a quarter of 
women aged 35–44 years (22.7%, 95% CI 20.0 to 25.6). 
No method use was highest among participants of Asian 
ethnicity and among those of Muslim and Hindu faith. 
Women without academic qualifications were significantly 
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Figure 2 Changes between Natsal-2 and Natsal-3 in the odds of long- acting reversible contraceptive (LARC) method use in the last year by demographic 
and lifestyle characteristics: sexually active* women aged 16–44 years.*Reporting vaginal sex in the last year. CI, confidence interval; FE, further education; 
OR, odds ratio.
more likely to report no method use, and those living 
in more deprived areas were significantly more likely to 
report non- use when compared with women living in the 
least deprived areas. Non- use was also significantly higher 
among those who were currently or previously married, 
those who reported no vaginal sex in the last 4 weeks, and 
those with one child.
There was more than a 10- fold increase in under-25- 
year- olds reporting current use of a LARC method from 
Natsal-2 to Natsal-3 (OR 11.35, 95% CI 3.23 to 39.87) 
compared with women 40 years and above (figure 2). 
A four- fold increase over time was seen among the 
25–29 years group. Use significantly increased among 
women who had never married compared with married 
women, (OR 3.41, 95% CI 2.29–5.09). A statistically 
significant increase was observed in the odds of use 
among those with fewer qualifications compared with 
those with more qualifications. A significant decline 
in the odds of current LARC use was observed among 
women with children compared with those with no 
children. No statistically significant differences were 
observed between the two surveys in relation to ethnicity, 
religion, and area of deprivation.
dISCuSSIon
In both Natsal-2 and Natsal-3, one in five women 
reported that they were currently using a contraceptive 
method in the most effective category. The transition 
from less effective to most effective use overall corre-
sponded with increased age, marriage, and having two 
or more children. No increase in overall most effective 
method use was observed among women, but significant 
increases in the odds of the implant and IUS use were 
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seen between the two surveys. Increases in LARC use 
were particularly evident among the under- 25s.
An increase in the use of LARC and a decline in ster-
ilisation have been observed in other countries.12 13 
In our analysis, while significant declines in male and 
female sterilisation were observed from 1999 to 2009, 
increased use of LARC was not sufficient to increase 
overall prevalence of most effective method use. Use of 
any contraceptive method is more cost effective than 
no method use; however, LARC methods have been 
found to be the most cost effective.14 15 A benefit of 
LARC methods over sterilisation is their reversibility, 
thus reducing both personal and financial costs for the 
small number of women who request reversal of steril-
isation, and their greater suitability for younger people 
wanting highly effective protection against pregnancy. 
Lack of awareness and concerns about insertion and 
removal procedures, side effects and perceived ‘perma-
nency’ of these methods are still barriers to uptake of 
LARC,16–18 but increasing accessibility and women’s 
knowledge (and removing any misconceptions) of 
these methods has been shown to have a significant 
impact on their uptake.19 Prescribing practice has also 
been found to be responsible for narrowing contra-
ceptive choice.20 21 The large increase in most effec-
tive method use among the under- 25s is promising and 
is an indication that knowledge and attitudes among 
both users and professionals may have shifted.
The oral contraceptive pill and condom are still the 
methods most commonly used, particularly among the 
young. Condoms are easily accessible and have the 
added benefit of STI protection. We grouped methods 
by the protection they offered against pregnancy rather 
than STIs. Condoms were grouped in the less effective 
category as we based the groups on typical failure rates, 
but if they are used consistently and correctly they offer 
good protection from both pregnancy and STIs. Nearly 
three- quarters of women report that they use condoms 
for exclusively pregnancy prevention compared with 
just over one in ten who use them exclusively for STI 
prevention.22 More effective contraceptive use could 
potentially have a negative consequence on STI rates 
if use of condoms declines as a consequence, so it is 
important that any education about these methods is 
given alongside messages on reducing risk of STIs. For 
the most part, it is still women who take responsibility 
for pregnancy prevention, and couples tend to move 
from condom to pill use as the relationship becomes 
more permanent and trusting.23
Contraceptive prevalence is high in Britain compared 
with other developed countries.24 However, another 
trend observed from our data was a significant increase 
between Natsal-2 and Natsal-3 in no method use among 
women who have had vaginal sex in the last year and 
were not currently pregnant. In their national proba-
bility survey of contraceptive behaviours among French 
women, Moreau and colleagues argue that even small 
changes in unmet contraceptive need contribute to the 
largest effects on unintended pregnancy rates within 
the general population.25 In Natsal-3, the highest preva-
lence of non- use (and less effective method use) among 
Asian participants and those of Muslim and Hindu faiths 
may be influenced by cultural norms around fertility, 
including less access to sexual and reproductive services, 
in some communities.26 27 It is notable that non- use was 
also higher among those without any academic quali-
fications and those living in more deprived areas, both 
factors which have been associated with unplanned 
pregnancy.3 While teenage pregnancies remain at a 
record low, abortion rates among women aged 25 years 
and older are rising and at a 10- year high.28 29
A strength of this study is that it provides national 
prevalence and trends at a population level. However, 
there are limitations that should be considered when 
interpreting the findings. The aim of our analysis was 
to present prevalence by contraceptive effectiveness 
category or non- use and to examine trends which 
would help inform public health initiatives and service 
provision. Therefore, we looked at crude, actual rates 
without adjustment for confounders to explore risk 
factors. Given the cross- sectional design of Natsal we 
could not reliability establish chronology and ascertain 
risk of unplanned pregnancy and current contraceptive 
method use or non- use. Numerous other socioeconomic 
and lifestyle trends including, perhaps most notably, the 
increase in the proportion of women entering higher 
education in Britain during the period in question, have 
had the potential to contribute to the increase in the 
use of LARC. Differences in population characteristics 
between Natsal-2 and Natsal-3 have been noted in other 
analyses, such as a decline in the proportion of women 
who are married or cohabiting.30 Although women 
were asked in Natsal about what sources they use to 
obtain contraceptive supplies they were not asked where 
they obtained specific methods, so it is not possible to 
determine who got what where and how this may have 
changed over time.27
Even a modest increase in effective contraceptive use 
results in financial savings and health gain.31 Eight in 10 
women in the UK aged between 16 and 44 years report 
that they are currently using a method of contraception, 
demonstrating the need for accessible contraceptive 
services. The analysis in this article suggests some success 
in the first decade of the 21st century in widening access 
to LARC methods across the sociodemographic spec-
trum. However, since 2014 QOF payments to counsel 
pill and patch users about LARC methods have been 
scrapped and since 2015 community contraceptive 
services have faced major cuts to funding.32 Findings 
from Natsal-4 will be due from 2023 and will help us 
better understand the impact of changes in population 
demographics and lifestyles and service cuts on contra-
ceptive use and reproductive outcomes.
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